Contact Molecules for Homologous Proteins | ||||
![]() [Full Bars] |
![]() [SiteTable] |
|
![]() [Back to Search Page] |
![]() [Back to HOMCOS] |
![]() [SupCon3D] |
![]() [help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | ![]() [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
2752856 | 925 | 125 | O95786(RIGI_HUMAN) | RecName: Full=Antiviral innate immune response receptor RIG-I ;AltName: Full=ATP-dependent RNA helicase DDX58 ; EC=3.6.4.13 ;AltName: Full=DEAD box protein 58;AltName: Full=RIG-I-like receptor 1; Short=RLR-1;AltName: Full=RNA sensor RIG-I ;AltName: Full=Retinoic acid-inducible gene 1 protein; Short=RIG-1;AltName: Full=Retinoic acid-inducible gene I protein; Short=RIG-I; |
QUERYSEQ |
MTTEQRRSLQAFQDYIRKTLDPTYILSYMAPWFREEEVQYIQAEKNNKGPMEAATLFLKFLLELQEEGWFRGFLDALDHAGYSGLYEAIESWDFKKIEKLEEYRLLLKRLQPEFKTRIIPTDIISDLSECLINQECEEILQICSTKGMMA GAEKLVECLLRSDKENWPKTLKLALEKERNKFSELWIVEKGIKDVETEDLEDKMETSDIQIFYQEDPECQNLSENSCPPSEVSDTNLYSPFKPRNYQLELALPAMKGKNTIICAPTGCGKTFVSLLICEHHLKKFPQGQKGKVVFFANQI PVYEQQKSVFSKYFERHGYRVTGISGATAENVPVEQIVENNDIIILTPQILVNNLKKGTIPSLSIFTLMIFDECHNTSKQHPYNMIMFNYLDQKLGGSSGPLPQVIGLTASVGVGDAKNTDEALDYICKLCASLDASVIATVKHNLEELE QVVYKPQKFFRKVESRISDKFKYIIAQLMRDTESLAKRICKDLENLSQIQNREFGTQKYEQWIVTVQKACMVFQMPDKDEESRICKALFLYTSHLRKYNDALIISEHARMKDALDYLKDFFSNVRAAGFDEIEQDLTQRFEEKLQELESV SRDPSNENPKLEDLCFILQEEYHLNPETITILFVKTRALVDALKNWIEGNPKLSFLKPGILTGRGKTNQNTGMTLPAQKCILDAFKASGDHNILIATSVADEGIDIAQCNLVILYEYVGNVIKMIQTRGRGRARGSKCFLLTSNAGVIEK EQINMYKEKMMNDSILRLQTWDEAVFREKILHIQTHEKFIRDSQEKPKPVPDKENKKLLCRKCKALACYTADVRVIEECHYTVLGDAFKECFVSRPHPKPKQFSSFEKRAKIFCARQNCSHDWGIHVKYKTFEIPVIKIESFVVEDIATG VQTLYSKWKDFHFEKIPFDPAEMSK |
925 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
region | name | description |
![]() |
1-925 | CHAIN | /note="Antiviral innate immune response receptor RIG-I" /id="PRO_0000144093" |
![]() ![]() |
1-87 | DOMAIN | /note="CARD 1" |
![]() ![]() ![]() |
92-172 | DOMAIN | /note="CARD 2" |
![]() ![]() ![]() |
251-430 | DOMAIN | /note="Helicase ATP-binding" |
![]() ![]() ![]() |
610-776 | DOMAIN | /note="Helicase C-terminal" |
![]() ![]() |
794-925 | DOMAIN | /note="RLR CTR" |
![]() ![]() |
218-925 | REGION | /note="Interaction with ZC3HAV1" |
![]() ![]() |
735-925 | REGION | /note="Mediates interaction with RNF135" |
![]() ![]() ![]() |
264-271 | BINDING | /ligand="ATP" /ligand_id="ChEBI:CHEBI:30616" |
![]() ![]() ![]() |
810-810 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" |
![]() ![]() ![]() |
813-813 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" |
![]() ![]() ![]() |
864-864 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" |
![]() ![]() ![]() |
869-869 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
1-925 | DISORDER | predicted by DISOPRED |
![]() |
|||||||
925 | |||||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
pdb_id | a1 | identity[%]2 | description | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | DDX58_HUMAN Antiviral innate immune response receptor RIG-I | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 55.7 | D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I | |||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
![]() |
|||||||
925 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RN135_HUMAN E3 ubiquitin-protein ligase RNF135[171 aa] | A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | RN135_HUMAN E3 ubiquitin-protein ligase RNF135[169 aa] | A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RN135_HUMAN E3 ubiquitin-protein ligase RNF135[178 aa] | A | 100.0 /100.0 |
13 /13 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
B | RN135_HUMAN E3 ubiquitin-protein ligase RNF135[178 aa] | C | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | UBC_HUMAN Ubiquitin[72 aa] | A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | UBC_HUMAN Ubiquitin[73 aa] | A | 100.0 /100.0 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | UBC_HUMAN Ubiquitin[73 aa] | B | 100.0 /100.0 |
11 /11 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() |
![]() |
Q | RL40_HUMAN Ubiquitin-60S ribosomal protein L40[73 aa] | H | 100.0 /99.5 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | A | 100.0 /99.5 |
11 /11 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | B | 100.0 /99.5 |
6 /6 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() |
![]() |
I | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | C | 100.0 /99.5 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | MAVS_HUMAN Mitochondrial antiviral-signaling protein[97 aa] | D | 100.0 /99.5 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
925 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3' | A | 100.0 /100.0 |
13 /13 |
DDX58_HUMAN RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3' | A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C).. | A | 100.0 /100.0 |
11 /11 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*(GDP)P*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C).. | A | 100.0 /100.0 |
3 /3 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*U)-3').. | A | 100.0 /100.0 |
18 /18 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*U)-3').. | A | 100.0 /100.0 |
27 /27 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*GP*AP*AP*UP*AP*UP*AP*AP*UP*AP*GP*UP*GP.. | A | 100.0 /100.0 |
40 /40 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(P*AP*AP*UP*AP*UP*AP*AP*UP*AP*GP*UP*GP*AP.. | A | 100.0 /100.0 |
37 /37 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | RNA (5'-R(*GP*GP*UP*AP*GP*AP*CP*GP*CP*UP*UP*CP*GP*.. | B | 100.0 /100.0 |
46 /46 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3').. | A | 100.0 /100.0 |
11 /11 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*C)-3').. | A | 100.0 /100.0 |
3 /3 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | dsRNA strand 1 | A | 100.0 /100.0 |
17 /17 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | dsRNA strand 2 | A | 100.0 /100.0 |
27 /27 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | dsRNA strand1 | A | 100.0 /100.0 |
14 /14 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | dsRNA strand 2 | A | 100.0 /100.0 |
24 /24 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DNA (41-MER) | A | 100.0 /100.0 |
17 /17 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3dsRNAa | A | 100.0 /100.0 |
24 /24 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | p3dsRNAb | A | 100.0 /100.0 |
21 /21 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p2dsRNA | A | 100.0 /100.0 |
26 /26 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | p2dsRNA | A | 100.0 /100.0 |
29 /29 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | OHdsRNA | A | 100.0 /100.0 |
27 /27 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | OHdsRNA | A | 100.0 /100.0 |
28 /28 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3SLR30 | A | 100.0 /100.0 |
41 /41 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3SLR30 | A | 100.0 /100.0 |
57 /57 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3SLR30 | A | 100.0 /100.0 |
33 /33 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | OHSLR30 | A | 100.0 /100.0 |
48 /48 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | OHSLR30 | A | 100.0 /100.0 |
55 /55 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | p3dsRNA24a | A | 100.0 /100.0 |
22 /22 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | p3dsRNA24a | C | 100.0 /100.0 |
21 /21 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | p3dsRNA24b | A | 100.0 /100.0 |
24 /24 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | p3dsRNA24b | C | 100.0 /100.0 |
16 /16 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | p3dsRNA24a | A | 100.0 /100.0 |
21 /21 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | p3dsRNA24b | A | 100.0 /100.0 |
19 /19 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3SLR30 | A | 100.0 /100.0 |
42 /42 |
RIGI_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | p3SLR14 | A | 100.0 /100.0 |
39 /39 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*CP*.. | C | 100.0 /99.8 |
19 /19 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RNA (5'-R(*CP*GP*AP*CP*GP*CP*UP*AP*GP*CP*GP*UP*CP*.. | C | 100.0 /99.8 |
29 /29 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | 5'-R-PPP(GP*GP*CP*GP*CP*GP*GP*CP*UP*UP*CP*GP*GP*CP.. | A | 100.0 /99.7 |
31 /31 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | 5'-R(*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP)-3' | A | 100.0 /99.5 |
16 /16 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 5'-R(*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP)-3' | A | 100.0 /99.5 |
16 /16 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*GP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*.. | A | 90.9 /99.2 |
11 /11 |
RIGI_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*GP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*.. | A | 100.0 /99.2 |
4 /4 |
RIGI_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*(GTP)P*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP.. | A | 93.3 /99.2 |
15 /15 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*(GTP)P*GP*CP*GP*CP*GP*CP*GP*CP*GP*CP*GP.. | A | 100.0 /99.2 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RNA (5'-R(*(ATP)P*UP*AP*UP*AP*UP*AP*UP*AP*UP*AP*U).. | A | 93.3 /99.2 |
15 /15 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RNA (5'-R(*(ATP)P*UP*AP*UP*AP*UP*AP*UP*AP*UP*AP*U).. | A | 100.0 /99.2 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 5'-R(*GP*CP*AP*UP*GP*CP*GP*AP*CP*CP*UP*CP*UP*GP *U.. | A | 28.6 /60.0 |
7 /7 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 5'-R(*UP*CP*AP*AP*AP*CP*AP*GP*AP*GP*GP*UP*CP*GP *C.. | A | 70.8 /60.0 |
24 /24 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 5'-R(*GP*CP*AP*UP*GP*CP*GP*AP*CP*CP*UP*CP*UP*GP *U.. | B | 28.6 /59.7 |
7 /7 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 5'-R(*UP*CP*AP*AP*AP*CP*AP*GP*AP*GP*GP*UP*CP*GP *C.. | B | 72.0 /59.7 |
25 /25 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 5'-R(*GP*GP*GP*AP*GP*AP*AP*CP*AP*AP*CP*GP*CP*GP)-3.. | A | 88.9 /55.3 |
9 /9 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | 5'-R(*GP*GP*GP*AP*GP*AP*AP*CP*AP*AP*CP*GP*CP*GP)-3.. | B | 100.0 /55.3 |
1 /1 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | 5'-R(*CP*GP*CP*GP*UP*UP*GP*UP*UP*CP*UP*CP*CP*CP)-3.. | A | 0.0 /55.3 |
2 /2 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 5'-R(*CP*GP*CP*GP*UP*UP*GP*UP*UP*CP*UP*CP*CP*CP)-3.. | B | 88.9 /55.3 |
9 /9 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
925 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ADP
|
A | 100.0 /99.4 |
14 /14 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
ADP
|
A | 78.6 /60.0 |
14 /15 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ADP
|
A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ADP
|
A | 100.0 /100.0 |
12 /12 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
M7G
|
A | 100.0 /100.0 |
7 /7 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GTP
|
A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GTP
|
A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
ANP
|
A | 91.7 /78.8 |
12 /12 |
DDX58_MOUSE RIG-I Helicase Domain |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
925 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
ZN
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /99.5 |
4 /4 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
A | 100.0 /99.2 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
A | 100.0 /99.2 |
4 /4 |
RIGI_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
ZN
|
A | 100.0 /99.7 |
4 /4 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /99.5 |
4 /4 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
C | 100.0 /99.8 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
ZN
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
ZN
|
A | 100.0 /100.0 |
4 /4 |
RIGI_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
HG
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
A | 100.0 /99.4 |
2 /2 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MG
|
A | 100.0 /60.0 |
5 /5 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
A | 100.0 /99.7 |
3 /3 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MG
|
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
MG
|
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MG
|
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MG
|
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MG
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
MG
|
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
P |
MG
|
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
U |
MG
|
E | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
MG
|
G | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
C | 100.0 /99.8 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
MG
|
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
MG
|
A | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CL
|
B | 100.0 /100.0 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CL
|
A | 66.7 /76.5 |
3 /3 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() |
![]() |
H |
CL
|
A | 100.0 /76.5 |
1 /1 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
CL
|
D | 0.0 /76.5 |
3 /3 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
NA
|
A | 100.0 /51.0 |
5 /5 |
IFIH1_HUMAN Interferon-induced helicase C domain-containing pr.. |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
925 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[495 aa] | A | 100.0 /100.0 |
40 /40 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[648 aa] | A | 100.0 /100.0 |
20 /20 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[641 aa] | A | 100.0 /100.0 |
26 /26 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
G | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[647 aa] | A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
K | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[644 aa] | A | 100.0 /100.0 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[647 aa] | C | 100.0 /100.0 |
11 /11 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[644 aa] | C | 100.0 /100.0 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[65.. | A | 100.0 /100.0 |
7 /7 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[65.. | A | 100.0 /100.0 |
6 /6 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[61.. | A | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[64.. | C | 100.0 /100.0 |
10 /10 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | DDX58_HUMAN Antiviral innate immune response receptor RIG-I[64.. | C | 100.0 /100.0 |
9 /9 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[188 aa] | A | 100.0 /100.0 |
21 /21 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[188 aa] | A | 100.0 /100.0 |
12 /12 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[188 aa] | A | 100.0 /99.5 |
3 /3 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() |
![]() |
H | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58[188 aa] | A | 100.0 /99.5 |
2 /2 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58[191 aa] | A | 82.4 /76.5 |
17 /17 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58[189 aa] | A | 72.7 /76.5 |
22 /22 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
925 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /99.5 |
7 /7 |
DDX58_HUMAN PROBABLE ATP-DEPENDENT RNA HELICASE DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
C |
SO4
|
A | 100.0 /100.0 |
7 /7 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /100.0 |
1 /1 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
GOL
|
A | 66.7 /55.3 |
6 /8 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 66.7 /55.3 |
3 /3 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
BEF
|
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
ETF
|
A | 100.0 /100.0 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
ETF
|
E | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
ETF
|
G | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
NA |
ETF
|
K | 100.0 /100.0 |
6 /6 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
BU3
|
A | 100.0 /100.0 |
7 /7 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
BU3
|
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
BU3
|
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
BU3
|
C | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
BU3
|
C | 100.0 /100.0 |
4 /4 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
BU3
|
C | 100.0 /100.0 |
8 /8 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
BU3
|
E | 100.0 /100.0 |
9 /9 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
BU3
|
G | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ALF
|
A | 100.0 /100.0 |
5 /5 |
DDX58_HUMAN Antiviral innate immune response receptor RIG-I |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
EDO
|
A | 100.0 /78.8 |
7 /7 |
DDX58_MOUSE RIG-I Helicase Domain |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /76.5 |
2 /2 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
B | 100.0 /76.5 |
1 /3 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
B | 100.0 /76.5 |
2 /2 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
C | 75.0 /76.1 |
4 /4 |
DDX58_MOUSE Probable ATP-dependent RNA helicase DDX58 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
AF3
|
A | 100.0 /60.0 |
9 /9 |
D3TI84_ANAPL RETINOIC ACID INDUCIBLE PROTEIN I |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |